ProPhase Labs, Inc. Common Stock, Value, Issued
ProPhase Labs, Inc. (PRPH) had Common Stock, Value, Issued of $7.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-19
- 2026-06-30: Common Stock, Value, Issued $7.00K.
- 2026-03-31: Common Stock, Value, Issued $7.00K.
- 2025-12-31: Common Stock, Value, Issued $4.00K.
- 2025-09-30: Common Stock, Value, Issued $29.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $7.00K 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $7.00K 10-Q/A · filed 2026-07-09 | |
| 2025-12-31 | $4.00K 10-Q · filed 2026-08-19 | |
| 2025-09-30 | $29.00K 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $29.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $29.00K 10-Q · filed 2025-05-20 | |
| 2024-12-31 | $1.00K 10-K · filed 2026-06-01 | $23.00K 10-K · filed 2025-04-01 |
| 2024-09-30 | $18.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $18.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $18.00K 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $18.00K 10-K · filed 2025-04-01 | |
| 2023-09-30 | $18.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $17.00K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $17.00K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $16.00K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $17.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $16.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $16.00K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $16.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $16.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $16.00K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $16.00K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $14.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $14.00K 10-Q · filed 2020-11-19 | |
| 2020-06-30 | $14.00K 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $14.00K 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $14.00K 10-K · filed 2021-03-31 | |
| 2019-09-30 | $14.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $14.00K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $14.00K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $14.00K 10-K · filed 2020-03-26 | |
| 2018-09-30 | $14.00K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $14.00K 10-Q · filed 2018-08-20 | |
| 2018-03-31 | $14.00K 10-Q/A · filed 2018-08-20 | |
| 2017-12-31 | $14.00K 10-K · filed 2019-03-26 | |
| 2017-09-30 | $13.00K 10-Q/A · filed 2018-08-20 | |
| 2017-06-30 | $13.00K 10-Q/A · filed 2018-08-20 | |
| 2017-03-31 | $13.00K 10-Q/A · filed 2018-08-20 | |
| 2016-12-31 | $13.00K 10-Q/A · filed 2018-08-20 | |
| 2016-09-30 | $13.00K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $13.00K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $13.00K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $13.00K 10-K · filed 2017-02-24 | |
| 2015-09-30 | $13.00K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $13.00K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $13.00K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $13.00K 10-K · filed 2016-03-29 | |
| 2014-09-30 | $12.00K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $12.00K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $11.00K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $11.00K 10-K · filed 2015-03-27 | |
| 2013-09-30 | $11.00K 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $11.00K 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $11.00K 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $11.00K 10-K · filed 2014-03-27 | |
| 2012-09-30 | $10.00K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $10.00K 10-Q · filed 2012-08-13 | |
| 2012-03-31 | $10.00K 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $10.00K 10-K · filed 2013-03-28 | |
| 2011-09-30 | $10.00K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $10.00K 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $10.00K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |